Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
NSAIDs API Market: By Molecule Type, By Formulation, and Region Forecast 2019 - 2030
NSAIDs API Market: By Molecule Type, By Formulation, and Region Forecast 2019 - 2030
NSAIDs API Market size was valued at US$ x million in 2023 and is poised to grow at a CAGR of x% from 2024-2030. owing to the increase in the prevalence of arthritis, which is the major cause of disability and a growing geriatric population across the globe drives the growth of the market. For instance, According to the Centers for Disease Control and Prevention (CDC), from 2013-2015, approximately 54.4 Mn US adults had some form of arthritis such as gout, rheumatoid arthritis treatment, fibromyalgia, and lupus, and estimated to reach 78 Mn adults aged 18 years older are projected to have arthritis by 2040. NSAIDs are a drug class that groups together drugs that provide analgesic and antipyretic effects.
Moreover, increasing access to healthcare with the rapid penetration of technology and other developments in the healthcare sector has increased the consumption of drugs, thereby directly creating positive impact on the NSAID market. However, the availability of alternative products in the market for NSAIDs and the development of advanced medications are expected to hamper the growth of the market. This report studies Global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the Global market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition.
Moreover, PBI analyzed Global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Global Market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in Global NSAIDs API.
Study Period
2024-2030Base Year
2023CAGR
x%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Low cost of the non-steroidal anti-inflammatory drugs such as ibuprofen, diclofenac, piroxicam, aspirin, and other drugs coupled with the better availability of the products boost the revenue growth of global NSAIDs market over the forecast years. Formulation of NSAIDs for the patient convenience also enhance the market revenue in the forthcoming years.
For instance, Pfizer, Inc. marketing the Flector (Diclofenac Epolamine Topical Patch) to treat acute pain due to minor strains, sprains, and bruises. In addition, NSAIDs also available in the injectable forms which are easy to administer the patients unable to swallow the tablets. Moreover, Mylan laboratories manufacturing Brufen effervescent granules that can be easily administered for the geriatric and paediatric patients
North America accounted for larger revenue share in global NSAIDs API market with significant CAGR and is expected to grow with highest CAGR during the forecast period owing to high demand for APIs in drug formulations and research and development programs in the region. Moreover, increasing preference towards generic medicine in the region enhances the growth of the market for APIs.
Asia Pacific holds second highest share in the global market due to presence of large number of generic manufacturers and increasing demand for generics in the region drives the market over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
x% |
|
By Molecule Type |
|
|
By Formulation |
|
|
By Region |
|
Download Free Sample Report
The global nsaids api market size was valued at US$ x million in 2023 and is projected to grow at a CAGR of x% from 2024 to 2030
Increased the consumption of drugs
Asia Pacific is the fastest-growing market
| 1. Executive Summary |
| 2. Global Nsaids Api Market Introduction |
| 2.1.Global Nsaids Api Market - Taxonomy |
| 2.2.Global Nsaids Api Market - Definitions |
| 2.2.1.Molecule Type |
| 2.2.2.Formulation |
| 2.2.3.Region |
| 3. Global Nsaids Api Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Nsaids Api Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Nsaids Api Market By Molecule Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Ibuprofen |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Aspirin |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Paracetmol |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Diclofenac |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Nsaids Api Market By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Tablets |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Capsules |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Suspension |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Topical Presentations |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Nsaids Api Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Nsaids Api Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Molecule Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Ibuprofen |
| 8.1.2.Aspirin |
| 8.1.3.Paracetmol |
| 8.1.4.Diclofenac |
| 8.1.5.Others |
| 8.2. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Tablets |
| 8.2.2.Capsules |
| 8.2.3.Suspension |
| 8.2.4.Topical Presentations |
| 8.2.5.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Nsaids Api Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Molecule Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Ibuprofen |
| 9.1.2.Aspirin |
| 9.1.3.Paracetmol |
| 9.1.4.Diclofenac |
| 9.1.5.Others |
| 9.2. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Tablets |
| 9.2.2.Capsules |
| 9.2.3.Suspension |
| 9.2.4.Topical Presentations |
| 9.2.5.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 9.3.7. |
| 10. Asia Pacific (APAC) Nsaids Api Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Molecule Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Ibuprofen |
| 10.1.2.Aspirin |
| 10.1.3.Paracetmol |
| 10.1.4.Diclofenac |
| 10.1.5.Others |
| 10.2. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Tablets |
| 10.2.2.Capsules |
| 10.2.3.Suspension |
| 10.2.4.Topical Presentations |
| 10.2.5.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Nsaids Api Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Molecule Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Ibuprofen |
| 11.1.2.Aspirin |
| 11.1.3.Paracetmol |
| 11.1.4.Diclofenac |
| 11.1.5.Others |
| 11.2. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Tablets |
| 11.2.2.Capsules |
| 11.2.3.Suspension |
| 11.2.4.Topical Presentations |
| 11.2.5.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Nsaids Api Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Molecule Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Ibuprofen |
| 12.1.2.Aspirin |
| 12.1.3.Paracetmol |
| 12.1.4.Diclofenac |
| 12.1.5.Others |
| 12.2. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Tablets |
| 12.2.2.Capsules |
| 12.2.3.Suspension |
| 12.2.4.Topical Presentations |
| 12.2.5.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Granules India Ltd. (India) |
| 13.2.2.Xinuha Pharm (China) |
| 13.2.3.IOL Chemicals and Pharmaceuticals Ld. (India) |
| 13.2.4.Strides Pharma Science Limited (India) |
| 13.2.5.SI Group (U.S.) |
| 13.2.6.BASF SE (Germany) |
| 13.2.7.Bayer AG (Germany) |
| 13.2.8.Pfizer, Inc. (U.S.) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.